Paneitz Dane C, Wolfe Stanley B, Giao Duc, Tessier Shannon N, Dageforde Leigh Anne, Elias Nahel, Rabi Seyed Alireza, Michel Eriberto, D'Alessandro David A, Osho Asishana A
From the Department of Surgery, Division of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Department of Surgery, Center for Engineering in Medicine & Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Ann Surg Open. 2024 Jan 8;5(1):e368. doi: 10.1097/AS9.0000000000000368. eCollection 2024 Mar.
To assess the effects of the 2020 United States Public Health Service (PHS) "Increased Risk" Guidelines update.
Donors labeled as "Increased Risk" for transmission of infectious diseases have been found to have decreased organ utilization rates despite no significant impact on recipient survival. Recently, the PHS provided an updated guideline focused on "Increased Risk" organ donors, which included the removal of the "Increased Risk" label and the elimination of the separate informed consent form, although the actual increased risk status of donors is still ultimately transmitted to transplant physicians. We sought to analyze the effect of this update on organ utilization rates.
This was a retrospective analysis of the Organ Procurement and Transplantation Network database which compared donor organ utilization in the 2 years before the June 2020 PHS Guideline update for increased-risk donor organs (June 2018-May 2020) versus the 2 years after the update (August 2020-July 2022). The organ utilization rate for each donor was determined by dividing the number of organs transplanted by the total number of organs available for procurement. Student test and multivariable logistic regression models were used for analysis.
There were 17,272 donors in the preupdate cohort and 17,922 donors in the postupdate cohort; of these, 4,977 (28.8%) and 3,893 (21.7%) donors were considered "Increased Risk", respectively. There was a 2% decrease in overall organ utilization rates after the update, driven by a 3% decrease in liver utilization rates and a 2% decrease in lung utilization rates. After multivariable adjustment, donors in the postupdate cohort had 10% decreased odds of having all organs transplanted.
The 2020 PHS "Increased Risk" Donor Guideline update was not associated with an increase in organ utilization rates in the first 2 years after its implementation, despite a decrease in the proportion of donors considered to be at higher risk. Further efforts to educate the community on the safe usage of high-risk organs are needed and may increase organ utilization.
评估2020年美国公共卫生服务部(PHS)“增加风险”指南更新的影响。
尽管对受者生存率没有显著影响,但被标记为传染病传播“增加风险”的捐赠者的器官利用率有所下降。最近,PHS发布了一份关于“增加风险”器官捐赠者的更新指南,其中包括取消“增加风险”标签和单独的知情同意书,尽管捐赠者实际增加的风险状况最终仍会传达给移植医生。我们试图分析这一更新对器官利用率的影响。
这是一项对器官获取与移植网络数据库的回顾性分析,比较了2020年6月PHS增加风险捐赠器官指南更新前2年(2018年6月至2020年5月)与更新后2年(2020年8月至2022年7月)的捐赠器官利用率。每个捐赠者的器官利用率通过将移植的器官数量除以可供获取的器官总数来确定。采用学生t检验和多变量逻辑回归模型进行分析。
更新前队列中有17272名捐赠者,更新后队列中有17922名捐赠者;其中,分别有4977名(28.8%)和3893名(21.7%)捐赠者被视为“增加风险”。更新后总体器官利用率下降了2%,主要是由于肝脏利用率下降了3%,肺利用率下降了2%。经过多变量调整后,更新后队列中的捐赠者将所有器官移植的几率降低了10%。
2020年PHS“增加风险”捐赠者指南更新在实施后的头两年与器官利用率的提高无关,尽管被认为风险较高的捐赠者比例有所下降。需要进一步努力向社区宣传高风险器官的安全使用,这可能会提高器官利用率。